Astellas Pharma (Japan)
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (Japan), Japan, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
46%
Total
Publications
4.9K
Total Open
Publications
2.3K
Total
Citations
146K
Open Access
Percentage
46%
Total
Publications
4.9K
Total Open
Publications
2.3K
Total
Citations
146K
Breakdown
Publisher Open
21%
Both
21%
Other Platform Open
4%
Closed
54%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 34%
700
Hybrid 32%
675
No Guarantees 34%
707
Other Platform Open
Domain 75%
931
Other Internet 19%
232
Institution 17%
211
Public 3%
41
Preprint 2%
27
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 929 |
DOI | Other Internet | 228 |
Europe PMC | Domain | 85 |
Royal Netherlands Academy of Arts and Sciences | Institution | 54 |
Figshare | Public | 39 |
Harris County Public Library | Institution | 26 |
Research Square | Preprint | 10 |
Yonsei University | Institution | 9 |
King's College London | Institution | 9 |
bioRxiv | Preprint | 9 |